Davunetide has published research citations on file; Selank does not yet — the main evidence gap between them.
Davunetide
Half-life
—
Selank
Half-life
60 minutes
| Your goal | Better option |
|---|---|
| Has published research citations | Davunetide |
| Further along in FDA review | Davunetide |
| More provider options (0 vs 166) | Selank |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Davunetide
Selank
Davunetide
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…
Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.
Selank
No citations on file.
About Davunetide
Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.
About Selank
Selank is believed to modulate the expression of GABA-A receptor subunits and increase BDNF levels, contributing to its anxiolytic and neuroprotective profile. It appears to regulate serotonin transporter gene expression and influence dopaminergic signalling. Unlike classical anxiolytics, it does not appear to produce tolerance or physical dependence in animal models.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Davunetide
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Selank
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Selank
Semax
Research suggests Semax and Selank may produce complementary cognitive and stress-modulating effects when combined. Semax is studied for BDNF upregulation and cognitive enhancement, while Selank is studied for anxiolytic and immune-regulatory activity — distinct mechanisms with potential overlap in neuroprotective signaling.
Davunetide
Not enough vendor pricing yet.
Selank
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Neuro & Cognitive Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Davunetide vs Selank — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/davunetide/selank